SIGA FY2025 operating income fell 66% to USD 23.7 million as product sales slid 34% to USD 88 million

Reuters
03/11
SIGA FY2025 operating income fell 66% to USD 23.7 million as product sales slid 34% to USD 88 million

SIGA reported Q4 product sales of USD 2.2 million, down 97%, and total revenues of USD 3.8 million, down 95%. Q4 operating loss was USD 9.5 million and net loss was USD 5.4 million. For FY 2025, product sales were USD 88 million, down 34%, and total revenues were USD 94.6 million, down 32%. FY 2025 operating income was USD 23.7 million, down 66%, while net income was USD 23.3 million, down 61%. The company said it received a USD 13 million Asia-Pacific procurement order for oral TPOXX in January, and CEO Diem Nguyen said SIGA is focused on securing new procurement contracts and orders in 2026 after generating USD 88 million in product revenues and USD 24 million in pre-tax operating income in 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SIGA Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603101601PRIMZONEFULLFEED9669392) on March 10, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10